ESMO Clinical Practice Guidelines: CNS Malignancies
The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.
The ESMO Clinical Practice Guidelines on Central Nervous System Malignancies currently focus on high-grade malignant glioma (newly diagnosed patients, glioblastoma (WHO grade IV) and anaplastic astrocytoma, oligoastrocytoma and oligodendroglioma (WHO grade III)) and include information on: incidence, diagnosis, staging and risk assessment, treatment, response evaluation and follow-up.
Central nervous system malignancies
High-Grade Malignant Glioma: ESMO Clinical Practice Guidelines
Published in 2014 Ann Oncol (2014) doi: 10.1093/annonc/mdu050 First published online: April 29, 2014
Authors: R. Stupp, M. Brada, M. J. van den Bent, J.-C. Tonn, G. Pentheroudakis